Anti-Obesity Medication Coverage by Payer in Michigan 2023 Quick Reference Guide

DOWNLOAD RESOURCE

Updated: 11/17/23

Quickly reference insurance provider coverage of anti-obesity medications, including phentermine, Lomaira (phentermine 8), Qsymia (phentermine-topiramate), Contrave (naltrexone HCI-bupropion HC), Saxenda (liraglutide), and Wegovy (semaglutide).
Providers include private Blue Cross Blue Shield of Michigan, HAP, and Priority Health, as well as public Medicare, Medicare Advantage, and Medicaid coverage.
Developed by the Michigan Collaborative for Type 2 Diabetes, last updated January 1, 2023 with 2023 Q1 formulary information.

Tags: For Providers, Point-of-care, Coverage Guides, Created By MCT2D, Handout

MCT2D Newsletter

Subscribe to the MCT2D Newsletter

Once per month we deliver news, updates, events, and more directly to you!

ccteam@mct2d.org